Work

Outcomes of high, t(11;14), and standard cytogenetic risk multiple myeloma following early high dose therapy and autologous hematopoietic cell transplantation (SCT).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.8583

Authors: Gregory Peter Kaufman, Morie A. Gertz, Angela Dispenzieri, Martha Lacy, Francis Buadi, David Dingli, Suzanne R. Hayman, Prashant Kapoor, S. Vincent Rajkumar, Shaji Kumar

Institution: Mayo Clinic

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2597869605

Cites:

Cited by:

Related to: 10